Proyurveda Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.16 Cr
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -91.53%
- Profit Growth 99.83%
- Ebitda 99.71%
- Net Worth -1.85%
- Total Assets -57.00%
About Proyurveda Lifescience
Proyurveda Lifescience Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 April 2015 (Nine years and nine months 13 days old ). Its registered office is in Valsad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.16 Cr, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Valsad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24233GJ2015PTC082953
-
Company No.
082953
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Apr 2015
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Proyurveda Lifescience?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Shah
|
Director | 22-Apr-2015 | Current |
|
Kunal Shah
|
Director | 22-Apr-2015 | Current |
Financial Performance of Proyurveda Lifescience.
Proyurveda Lifescience Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 91.53% decrease. The company also saw a substantial improvement in profitability, with a 99.83% increase in profit. The company's net worth dipped by a decrease of 1.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proyurveda Lifescience?
In 2022, Proyurveda Lifescience had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Essenzaa Nutrition Private LimitedKunal Shah is a mutual person
-
Maximaa Systems LimitedManoj Shah is a mutual person
-
Herbonation Healthcare Private LimitedKunal Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Proyurveda Lifescience?
Unlock and access historical data on people associated with Proyurveda Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proyurveda Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proyurveda Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.